gB structure determination. Construct gBΔ 71, which lacks the signal peptide and proteolytically sensitive N terminus (Fig. 1a) , was crystallized in a mixture of detergent and short amphipathic polymers (amphipols) 20 , yielding two crystal forms (Table 1 and Supplementary Fig. 1 ). The 3.6-Å-resolution P321 structure and the 4.1-Å-resolution H32 structure were determined by molecular replacement using the ectodomain structure 9 as a search model. The MPR and most of the TMD were resolved in both crystal forms, likely owing to restriction of TMD movement by multiple interac-Viral fusogens merge viral and cell membranes during cell penetration. Their ectodomains drive fusion by undergoing largescale refolding, but little is known about the functionally important regions located within or near the membrane. Here we report the crystal structure of full-length glycoprotein B (gB), the fusogen from herpes simplex virus, complemented by electron spin resonance measurements. The membrane-proximal (MPR), transmembrane (TMD), and cytoplasmic (CTD) domains form a uniquely folded trimeric pedestal beneath the ectodomain, which balances dynamic flexibility with extensive, stabilizing membrane interactions. The postfusion conformation of the ectodomain suggests that the CTD likewise adopted the postfusion form. However, hyperfusogenic mutations, which destabilize the prefusion state of gB, target key interfaces and structural motifs that reinforce the observed CTD structure. Thus, a similar CTD structure must stabilize gB in its prefusion state. Our data suggest a model for how this dynamic, membrane-dependent 'clamp' controls the fusogenic refolding of gB. NatuRE StRuCtuRal & MolECulaR BioloGy | VOL 25 | MAY 2018 | 416-424 | www.nature.com/nsmb 416
H erpesviruses infect most of the world's population for life by establishing latent infections from which they periodically reactivate. The three subfamilies of herpesviruses-α , β , and γ -have distinct replication strategies and pathogenesis. α -herpesviruses, which include herpes simplex viruses type 1 and 2 (HSV-1 and HSV-2), cause skin lesions, encephalitis 1 , and keratitis 2 . β -herpesviruses, including cytomegalovirus (CMV), are frequently asymptomatic but cause disseminated infections in immunocompromised patients, for example, transplant recipients 3 , and developmental abnormalities in neonates 4 . γ -herpesviruses, which include Epstein-Barr virus 5 (EBV), are linked causally to several cancers.
All herpesviruses have similar virion structures and penetrate cells by using multiple viral and host proteins 6 to catalyze a merger of their viral envelope with a host cell membrane. In HSV-1 and HSV-2, fusion requires four essential viral surface glycoproteins-gB, gD, gH, and gL-in addition to host receptors for gD and, potentially, other viral and host molecules 6 . Fusion by other herpesviruses also depends on the core entry glycoproteins gB, gH, and gL, paired with different tropism-determining partners 7 .
The conserved surface glycoprotein gB is a fusogen. Viral fusogens are type I membrane proteins anchored in the viral envelope that merge the viral and cell membranes during cell entry. They engage both membranes and are thought to provide energy to drive fusion by refolding from a high-energy prefusion to a low-energy postfusion conformation 8 . Structures of the soluble extracellular portions (or ectodomains) of many viral fusogens in both conformations revealed large-scale fusogenic rearrangements and pinpointed the location of the hydrophobic fusion peptides, or loops, that bind target cell membranes. Several crystal structures of gB ectodomains in the postfusion conformation [9] [10] [11] [12] and a cryoelectron tomography (cryo-ET) reconstruction of an alternative conformation of HSV-1 gB on the surface of exosomes are available.
In addition to the ectodomain, gB contains three other regions: an external MPR, a single-pass TMD, and an intraviral, or cytoplas-mic, domain (CTD). These domains represent ~20% of the polypeptide and are essential for fusion [13] [14] [15] [16] . The CTD also restrains the fusogenic activity of gB. Point mutations, insertions, or truncations within this domain increase cell-cell fusion in the context of infected cells or uninfected cells transfected to express core entry glycoproteins, and are referred to as hyperfusogenic 14, [17] [18] [19] . But, in the absence of any structural information, the mechanistic contributions of the MPR, TMD, and CTD to the gB-mediated fusion process remain unexplained.
Here we report the crystal structure of full-length gB from HSV-1, in which the MPR-TMD-CTD forms a uniquely folded trimeric pedestal underneath the ectodomain. The structure and complementary electron spin resonance measurements reveal that the dynamic nature of this pedestal is offset by extensive, stabilizing membrane interactions. While the CTD trimer is appended to the postfusion ectodomain, hyperfusogenic mutations target trimeric interfaces and structural motifs within the CTD or its membraneinteracting elements, all of which stabilize the observed structure. Thus, the hyperfusogenic phenotype of the corresponding mutants can only be rationalized if the prefusion conformation of the CTD has a similar structure. We propose that the ordered, membranebound CTD acts as a clamp that restrains the fusogenic activity of gB by stabilizing the ectodomain in its prefusion conformation.
HSV-1 gB harboring a point mutation of residue G766 or F770 does not complement gB-null virus despite adequate surface expression 15 .
The TMD trimer has an inverted teepee shape. The TMD forms a nearly straight helix positioned perpendicular to the MPR helix ( Fig. 1c ). It includes a hydrophilic fragment previously assigned to the CTD that extends beyond the cytoplasmic face of the lipid bilayer (Fig. 1b) . The three symmetry-related TMD helices cross at a ~46° angle to form a unique inverted teepee ( Figs. 1 and 2a,b ), in which each protomer buries ~770.5 Å 2 of its accessible surface area (ASA). At the N terminus, the TMD helices are splayed and do not interact. Although the TMD trimer does not resemble a classic coiled coil, its narrow C terminus (residues A791-V798) is stabilized by knob-inhole packing (Fig. 2c) . The close fit of the TMD helices is enabled by the small or absent side chains of G787, A790, A791, and A794 ( Fig. 2a ). These residues are completely conserved among α -herpesviruses, implying a similar TMD arrangement ( Supplementary Fig. 3 ). More distantly related β -and γ -herpesviruses ( Supplementary Fig. 2a ) have bulky residues at these positions, so their TMDs likely cross at different points and angles. Interactions between the hydrophilic C termini of the TMD helices and the CTD further stabilize this representations. The ectodomain rests atop a pedestal formed by the MPR-TMD-CTD trimer. All three protomers are colored by domain in the surface view, whereas in the cartoon view only one protomer is colored by domain. The inferred location of the membrane is shown schematically using peach (hydrophobic core) and light blue (polar headgroups) boxes. c, Secondary structure elements of the MPR-TMD-CTD pedestal are shown in an isolated protomer. d, Three views of the trimeric MPR-TMD-CTD pedestal, in which one protomer is colored by domain.
Articles

NaTuRe STRuCTuRal & MOleCulaR BiOlOgy
bundle. In the H32 structure, the TMD helices are more loosely packed, being unrestrained by the CTD ( Supplementary Fig. 4 ).
The MPR-TMD hinge contains two invariant residues, P774 and G776 ( Supplementary Fig. 2a -c), but is unresolved and likely flexible. The greater MPR-TMD angle in the H32 structure (~100° versus ~92°) further indicates that this is a dynamic region. This hinge is essential for proper gB folding 15, 21 and may help orient the MPR relative to the TMD.
The CTD forms an intertwined trimer. The resolved portion of the CTD-the CTD core-consists of two α -helices (h1a and h2) and one 3 10 helix (h1b) ( Fig. 1c ). h1a and h1b form an elbow that juts outward toward the margin of the trimer, while the long h2 helix crosses beneath the molecule and angles up toward the membrane. The unresolved linker connecting h1b and h2 is poorly conserved in sequence and length, even among the closely related α -herpesvirus homologs. It likely has a limited functional role because mutations within it, such as the E830S E831S double mutation, have no obvious effect on fusion efficiency 22 . The TMD and h1a and h1b helices create a zigzag ( Supplementary Fig. 2c ). Residues P805 and P811 lie at the TMD-h1a and h1a-h1b junctions, respectively ( Supplementary  Fig. 2c ), and likely stabilize this unusual structure, given the tendency of prolines to disrupt helices and create sharp bends 23 in both soluble and membrane environments. These two prolines are the only invariant CTD core positions among all herpesviruses ( Supplementary Fig. 2a ), which suggests that the zigzag is an essential conserved structural element within the TMD-CTD module.
Below the proline zigzag, the remaining CTD core residues form a triangular base stabilized by multiple interactions (Figs. 2d and 3,  and Supplementary Table 1 ). Each protomer buries ~2,051 Å 2 of ASA, with helix h2 embraced by helices h1a, h1b, and h2 of one neighbor and contacting helices h1a, h1b, and h2 of the other neighbor ( Figs. 1d and 2d ). The trimeric CTD interface is highly conserved among α -herpesviruses ( Supplementary Figs. 3 and 5 ) and is likely functionally important.
Charge distribution and orientation in the membrane. The placement of MPR-TMD-CTD in the membrane was inferred from the surface distribution of hydrophobic, polar, and charged residues ( Fig. 3a ). Both the hydrophobic TMD and the hydrophobic MPR helix are embedded in the hydrocarbon core, with only the serine spine formed by the S762, S765, and S769 side chains protruding into the headgroups of the outer leaflet ( Fig. 3a,b ). This arrangement places the ectodomain fusion loops into the headgroups of the outer leaflet, consistent with binding of isolated gB ectodomain to membranes 24 . Such deep MPR placement within the membrane is expected in other homologs on the basis of conservation of hydrophobic and polar residues (Supplementary Fig. 2a ) and suggests that the MPR helices may promote fusion by facilitating lipid mixing.
On the opposite side of the bilayer, the side chains of R796 and R800 in the TMD and K807, R858, K862, K864, and K865 in the CTD form a positively charged 'belt' (Fig. 3a ). Most of these residues are highly conserved in α -herpesviruses, and even gB homologs from β -and γ -herpesviruses have at least one basic residue at the TMD C terminus and the h2 C terminus ( Supplementary Fig. 2a ). This 'basic belt' could help brace the CTD against the membrane.
In contrast, the CTD base is negatively charged and rich in acidic residues (D834, D836, E837, E842, and E845) ( Fig. 3c ). Among 13 α -herpesvirus gB homologs ( Supplementary Fig. 3 ), D836 is invariant and the other four residues are conserved. At several of these positions, substitutions that eliminate negative charge reduce the electrostatic potential of the CTD base. Yet, the distinct phenotypes of these mutants imply that different sections of this 'acidic face' have specific functional roles. The D836A mutant of HSV-2 gB is hyperfusogenic in virus-free cell-cell fusion assays 25 , and the D836 residue, located on the periphery of the CTD core, could participate in fusion by accepting fusion-triggering input from the gH cytotail 22 . Conversely, E842S and E845S mutations in the HSV-1 gB have no effect on fusion in the same assay 22 , and these sites might instead provide a docking site for a positively charged binding partner, for example, a tegument protein, during viral morphogenesis.
A membrane-anchoring helix within the CTD C terminus. The CTD C terminus, residues 866-904, is unresolved in the crystal structure. This region restrains the fusogenic activity of gB, as its truncation leads to a syncytial phenotype 26 . It contains a putative amphipathic helix, h3, that forms in the presence of membranes and enables stable attachment of isolated CTD to membranes 19 .
To determine the structure of the CTD C terminus and its orientation within the membrane, we employed continuous-wave electron spin resonance spectroscopy (CW-ESR) on isolated CTD, residues 801-904, bound to synthetic membrane vesicles composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate (POPA) in 1:1 molar ratio. Single-cysteine CTD mutants from H861C to K885C were expressed in Escherichia coli, purified, and spin labeled. Mutations preserved gB fusogenicity, as assessed by virus-free cell-cell fusion assay ( Supplementary Fig. 6 and Supplementary Note 1), and likely did not globally perturb membrane interactions. 
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All CW-ESR spectra in solution displayed narrow, sharp peaks characteristic of a highly mobile spin label attached to unstructured protein ( Fig. 4a ). In contrast, the peaks of CW-ESR spectra collected in the presence of acidic liposomes were broadened to varying degrees, indicating restricted spin-label mobility 27 (Fig. 4a ) and suggesting that residues H861-K885 become less dynamic upon membrane binding. The depth of spin-label insertion (Fig. 4b ) into the membrane was determined from CW-ESR microwave power saturation analysis of each position's Ni(II)-diammine-2,2'-(ethane-1,2-diyldiimino) diacetic acid (NiEDDA) and O 2 accessibility ( Supplementary Fig. 7a ). The depth follows a periodic pattern for V876-R884, with a period of ~3.65 residues, similar to the ideal α -helix periodicity of 3.6, and we conclude that this span forms an amphipathic helix straddling the boundary of the headgroup and aqueous interface (Fig. 4c ). The ESR-derived boundaries of h3 are consistent with secondary structure predictions and the proteolytic sensitivity of the isolated CTD 26 , whereas the variable insertion depth along h3 suggests that it is kinked or otherwise distorted. The deepest residue, M879C, approaches the bilayer core location of the spin-labeled lipid 1-palmitoyl-2-stearoyl-(5-doxyl)-sn-glycero-3-phosphocholine (5PC), while the rest of the residues lie near the headgroup and aqueous interface. Structural features identified through the depth analysis were confirmed by the mobility pattern ( Supplementary Fig. 7b ), with the mobility of residues in h3 reflecting both their containment in this structural element and the extent to which membrane interactions confine them. Thus, binding of the unstructured CTD C terminus to the bilayer transforms it into a shallow membrane anchor composed of an amphipathic helix, one face of which interacts with the polar headgroups. Amphipathic helices are also found in the HIV Env CTD 28 and the fusion peptide of influenza hemagglutinin (HA) 29 and may be employed by fusogens to grip the membranes they remodel.
DEER analysis of free and membrane-bound CTD.
Formation of helix h3 in the presence of membranes is accompanied by global organization of the CTD, as determined by double electron-electron resonance (DEER) spectroscopy on isolated CTD. The CTD is a trimer in solution 19 , which allowed us to obtain interprotomer distance distributions between symmetry-related spin labels introduced by single-cysteine mutations S803C, E816C, or E830C ( Fig.  5a ). Distance distributions for all mutants in solution were broad and centered at ~40 Å but narrowed in the presence of anionic liposomes ( Fig. 5b) , indicating that S803, E816, and E830 lie in highly dynamic regions that become more ordered upon membrane binding. This concurs with the increase in helicity and decrease in proteolytic susceptibility of the CTD in the presence of anionic liposomes 26 .
Of the three CTD mutants, E816C displayed the closest agreement between the center of its membrane-bound DEER distance distribution and the E816(Cα )-E816′ (Cα ) crystal structure distance (where the prime symbol denotes a neighboring protomer), with measurements of ~32 Å ( Fig. 5b ) and 31.98 Å (Fig. 5a ), respectively. The distance distribution for the membrane-bound S803C mutant was centered at ~24 Å ( Fig. 5b) , which is longer than the ig. 2 | Residues involved in formation of the trimeric MPR-tMD-CtD pedestal. a, TMD helices interact exclusively through hydrophobic residues (yellow and orange side chains), which mediate both hydrophobic contacts (side chain atoms) and van der Waals contacts (main chain atoms). b, Surface representation of a emphasizing contact between the helices, in three views. c, A subset of the TMD interface residues participate in a stabilizing knob-inhole interaction, where A791, A794, F795, and V798 (orange) form a hole into which the A794 (pink) knob of the neighboring protomer fits. d, Side and top views of the CTD showing residues that form salt bridges and hydrogen bonds (pink) or hydrophobic interactions (yellow). Salt bridges and hydrogen bonds are indicated by dotted black lines.
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S803(Cα )-S803′ (Cα ) distance of 18.11 Å in the crystal structure ( Fig. 5a ). Similar differences between interspin and backbone measurements have been reported previously 30, 31 and typically reflect contributions from the length and relative positions of spin-label tethers. The lower-than-expected signal intensity observed with both the membrane-bound S803C and E816C mutants ( Fig. 5b ) may indicate that spin label at these positions destabilizes the folded CTD structure.
In the third mutant, E830C, strong signal in the presence of membrane and the relatively broad distance distribution are consistent with the position of the residue in a flexible loop. Yet, while this distribution is centered at ~28 Å (Fig. 5b ), the E830(Cα )-E830′ (Cα ) distance in the crystal structure is 45.64 Å (Fig. 5a ). We hypothesize that, when the CTD binds the membrane bilayer, the E830containing loop becomes more ordered and compact. Additionally, crystal packing of gBΔ 71 or absence of the TMD in the ESR constructs could affect the conformation of this loop.
Fusion regulation by the CTD. The gBΔ 71 crystal structure together with ESR measurements provides an excellent model for understanding fusion regulation by the CTD. Certain mutations in the CTD and the TMD C terminus result in enhanced or impaired cell-cell fusion. We classified all known fusion-altering mutations in HSV-1 or HSV-2 gB on the basis of their location in and potential effect on the structure ( Fig. 6 and Supplementary Table 2 ), regardless of whether they were identified in clinical HSV isolates or engineered.
The largest group of hyperfusogenic mutations 14, 17, 22, 25, [32] [33] [34] [35] [36] , group 1, targets residues located at the trimeric CTD interfaces. These mutations are predicted to disrupt interprotomer bonds, including hydrogen bonds (Y810A 25 , Y849A 14 , S854F 32 , E857A 25 , and E857D 33 ), van der Waals contacts (T813I 17 ), and hydrophobic contacts (V853A 25 ), owing to side chain substitutions. Group 2 contains the P805A 25 and T859P 37 mutations that could indirectly destabilize trimeric interfaces by disrupting important structural elements, the zigzag structure and helix h2, respectively. Group 3 contains mutations that target the basic belt, a membrane-binding element: R796A 17 and R800A 17 in the TMD and R858H 34, 38 and R858C 17 , K864S 22 , and K865S 22 in the CTD. These mutations probably weaken membrane interactions of the CTD by reducing the positive charge in the vicinity of the membrane. Group 3 also contains truncations of helix h3 18, 26, 39 . Eliminating this important membrane anchor reduces the kinetic energy barrier that gB must overcome during prefusion-to-postfusion refolding 22, 40 in HSV-1 18, 26, 39 and EBV [40] [41] [42] . A similar mechanism may account for enhanced fusion in HIV Env truncation mutants 43 . Finally, group 4 contains mutations for which the hyperfusogenic phenotype cannot yet be readily explained. These mutations include D836A 25 and A855V 35, 44 in h2 as well as L817P 36 , L817H 35 , and insertions between E816 and L817 34 in the region immediately preceding the unresolved CTD loop. All of these residues are located at the periphery of the CTD core and could accept fusion-triggering input from the gH cytotail 22 . Nevertheless, most hyperfusogenic mutations map to either the trimeric or membrane interfaces and would be expected to disrupt either the CTD trimer or its membrane interactions.
Unlike hyperfusogenic mutants, CTD mutants that fuse poorly are uncommon and are typically expressed on the cell surface at very low levels 25 , likely due to protein misfolding. Structure analysis shows that most of the corresponding mutations shorten the side chains of hydrophobic residues along the trimeric CTD axis and likely eliminate interactions critical for basal CTD trimer stability (Fig. 6b ). The only known CTD mutation that reduces the rate of viral entry despite adequate surface expression, A851V 17 , may impede fusion by increasing the number of hydrophobic contacts at the trimeric interface and further stabilizing the CTD trimer.
The clustering of hyperfusogenic mutations in the CTD indicates that a central function of this domain is stabilization of gB in its prefusion form. Given that these mutations map to key interfaces and structural motifs of the observed CTD structure, their phenotype can only be rationalized if this or a similar structure exists in the prefusion gB. We propose that the membrane-bound, trimeric CTD structure, observed in the crystals and inferred from the ESR data, is essential for restraining the fusogenic activity of gB.
Discussion
Many viral fusogens require regions lying within or near the membrane for activity. In HIV Env, the MPER houses the epitopes of several broadly neutralizing antibodies 45 , whereas the TMD influences its conformation, stability, and antigenicity 46 . In influenza HA, the 
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TMD is required to bring fusion to completion 47 . Additionally, the CTDs of herpesvirus gB 17, 41, 48 , HIV Env 45 , and paramyxovirus F 49 can control the fusogenic activity of their ectodomains across the membrane. However, structural information on these juxta-membrane regions is limited. Structures of the isolated MPER and TMD of HIV Env have been determined by NMR 46, 50 , but no structures for large, lipid-associated CTDs have been described. Moreover, the only available high-resolution structures of full-length fusogens are of class II fusogens from dengue 51 and Zika 52 viruses, which lack CTDs and have 'hook-shaped' TMDs that do not span the membrane.
Here we presented the most complete structure of a fusogen with a membrane-spanning TMD and a large CTD. The gB structure shows that the MPR-TMD-CTD forms a uniquely folded trimeric pedestal beneath the ectodomain that interacts extensively with the membrane. The structure defines TMD boundaries more precisely and identifies regions of potential functional importance throughout the pedestal, including the MPR serine spine and the basic belt and acidic face of the CTD. Membrane binding organizes the CTD core and is accompanied by formation of the C-terminal amphipathic helix, a stabilizing bilayer anchor.
Collectively, structure-based analysis of a large panel of fusionaltering CTD mutations 17, 25, [34] [35] [36] 38 indicates that CTD trimerization is essential for gB folding and surface expression. Proper regulation of fusogenic activity further requires membrane binding of this trimer. The postfusion conformation of the gBΔ 71 ectodomain suggests that the CTD pedestal was also captured in its postfusion form. However, because hyperfusogenic mutations both disrupt elements that rein-force the observed CTD trimer structure and destabilize prefusion gB, a similar structure must stabilize the prefusion gB. Therefore, we hypothesize that, unlike the ectodomain, the CTD adopts similar conformations in the prefusion and postfusion states. Nevetheless, it is possible that the gBΔ 71 structure is a hybrid of a postfusion ectodomain and a prefusion CTD, made possible by the amphipol and crystal packing, whereas the postfusion CTD structure is quite different.
We propose that the CTD-including the core observed in the crystals and the C-terminal amphipathic helix-constitutes an inhibitory membrane-dependent clamp that stabilizes the gB ectodomain in its prefusion conformation. Lacking this clamp, isolated gB ectodomain adopts only the postfusion conformation 9, 53 . Moreover, the fully folded CTD clamp requires intact membrane, which explains why even full-length gB adopts the postfusion conformation upon detergent solubilization (this work and ref. 54 ). Solubilization disrupts the bilayer scaffold surrounding gB and destabilizes the CTD clamp, enabling the ectodomain to refold into the postfusion conformation. In agreement with this hypothesis, non-postfusion gB conformations have thus far only been observed in gB-containing exosomes 55, 56 . Our results illustrate the need to study complete fusogens in a bilayer environment, especially those containing large membrane-anchoring segments.
The gB structure presented here may help illuminate its unusual activation mechanism. All viral fusogens face the challenge of deploying at the correct moment. Class I and class II fusogens rely upon priming systems that involve proteolytic cleavage of an inactive precursor or chaperone to prevent premature activation, whereas vesicular stomatitis virus (VSV) G and gp64 from class III circumvent the issue through 
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reversible conformational rearrangements 8 . Lacking both a priming 'safety system' and the ability to regain its prefusion state, gB is instead stabilized in its prefusion conformation by its CTD and activated by other glycoproteins including the gH-gL heterodimer.
Although the ectodomain of the gH-gL heterodimer is thought to activate gB by directly binding its ectodomain 6 , the 14-residue gH cytotail is also essential for gB activation 57, 58 . Cell-cell fusion is reduced by truncations of the gH cytotail. Moreover, fusion levels are proportionate to the length of the remaining gH cytotail 22 such that an eight-residue tail maintains efficient fusion, a five-residue tail has twofold reduced fusion, and further truncations yield progressively lower fusion levels until a one-residue tail achieves only background fusion levels. Although the precise role of the gH cytotail remains unclear, we hypothesize that it releases the gB clamp by acting as a wedge that disrupts either CTD core or its membrane interactions. Because its effectiveness is vastly reduced by truncation, the gH cytotail must be able to reach a certain point on the gB CTD to do this 22 . Its potential targets could thus be any CTD features that stabilize the gB clamp; for example, interprotomer contacts in the CTD core or h3-membrane interactions. An extended eight-residue peptide would nearly span the height of the gB CTD and could interact with the CTD at multiple sites. Hyperfusogenic HSV-1 gB constructs still require activation by gH-gL heterodimer and are sensitive to gH tail length 22 . Yet, they achieve higher fusion levels with shorter gH cytotails, probably because their mutated clamps are on a 'hair trigger' and are more easily released.
Combining our structure analysis and the published data, we propose a 'clamp-and-wedge' model of HSV fusion (Fig. 7) . The CTD clamp initially restrains the gB ectodomain in its high-energy prefusion form by an unknown mechanism. Binding of gD to one of its receptors results in activation of the gH-gL heterodimer, prompting the gH cytotail wedge to interact with the CTD clamp and destabilize it in some manner. Freed from the CTD's restraining influence, the prefusion ectodomain then refolds irreversibly into its thermodynamically favored postfusion conformation while the CTD returns to its initial conformation. This mechanism for releasing the CTD clamp may explain why multiple glycoproteins are required to activate gB in both HSV-1 and other herpesvirus 
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homologs. Although the CTD trimer must be destabilized during fusion, it does not need to come apart completely. Major ectodomain rearrangements coupled to restricted CTD motion could be accommodated by asymmetric refolding of the ectodomain 8 and extensive rearrangement of the flexible MPR. However, if the observed CTD trimer represents solely the prefusion form, this domain could undergo permanent refolding or unfolding during fusion.
To influence the ectodomain conformation, the CTD must convey its own status through the intervening MPR and TMD. Extension of the TMD helices beyond the inner leaflet and into the CTD 'space' could enable them to serve as levers to efficiently transmit CTD movements to the TMD. Indeed, when the CTD core is ordered, the TMD helices are fully assembled into an inverted teepee. However, a disordered CTD core enforces no such constraints on the TMD. This contrast is an extreme example of how rearrangements in the regulatory CTD might propagate across the membrane. Nevertheless, the same pathway could transmit smaller, functionally relevant conformational changes within the CTD due to syncytial mutations or in response to a fusion-triggering signal.
How the CTD status is transmitted to the ectodomain through the MPR is less clear. The N terminus of the MPR is unresolved in both of our structures and, as the visible C terminus (the MPR helix) does not appear to contact the postfusion ectodomain extensively enough to influence either its stability or conformation, this domain likely looks very different in prefusion gB. Furthermore, if the prefusion and postfusion CTD conformations are indeed similar, major rearrangement of the MPR (and possibly the TMD) may be necessary to couple the CTD to the vastly different ectodomain conformations that are predicted.
Our model of full-length HSV-1 gB provides a first look at its fusion-restraining clamp as well as the most comprehensive picture of the membrane-interacting domains of any fusogen containing a membrane-spanning TMD and a large CTD. Given the many ways in which the structure of this clamp is dependent on the surrounding viral envelope, we hypothesize that the structure and function of the herpesvirus fusogen gB are uniquely controlled by the membrane. This new paradigm provides a starting point for exploring the persistent mysteries that surround gB, such as the nature of its interaction with the gH-gL heterodimer and the structure of its prefusion conformation.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41594-018-0060-6. Fig. 7 | the clamp-and-wedge model of HSV fusion. The CTD clamp restrains the gB ectodomain in its high-energy prefusion form. Binding of gD to one of its receptors, herpes virus entry mediator (HVEM) or nectin, (1) relieves it from an autoinhibited dimeric state (not shown) and results in activation of the gH-gL heterodimer (2) . The ectodomain of activated gH-gL heterodimer interacts with the gB ectodomain, while the gH cytotail releases the clamp by wedging between the intertwined CTD protomers (3). The destabilized clamp loses its hold on the ectodomain, and gB proceeds to refold into its thermodynamically favored postfusion conformation, drawing the virion and cell membranes together (4) . The clamp then returns to its initial conformation (5) .
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Methods Construction of gB CTD mutants. Sequences encoding single-cysteine CTD mutants were cloned into pET24b. Many mutants were subcloned into pKH52 (wild-type CTD with a C-terminal His 6 tag) from plasmids encoding equivalent full-length gB (FL-gB) single-cysteine mutants with PstI and XhoI. Others were prepared with a QuikChange PCR strategy using the primers listed in Supplementary Table 3 . Finally, some constructs were prepared using 'splicing overlap extension' PCR (SOE PCR) to modify the pKH52 construct.
Construction of full-length gB for functional assays. The sequences for FL-gB constructs with single cysteine mutations were cloned into the pCAGGS background. The K862C, K864C, K865C, K866C, V876C, T877C, D878C, M879C, V880C, M881C, R882C, K883C, R884C, and R885C mutants were generated in pPEP98 (wild-type FL-gB) by SOE PCR. Other FL-gB single-cysteine mutants, namely S803C, E830C, H861C, A863C, G867C, T868C, S869C, A870C, L871C, L872C, S873C, A874C, and K875C, were subcloned from the equivalent gB CTD single-cysteine mutant expression construct with SacI and XhoI. To facilitate this process, a modified pPEP98 construct called pRC30 was created in which an XhoI site was introduced after codon 904 while other SacI and XhoI sites were destroyed. This resulted in amino acids LE between residue 904 and the stop codon. All primers are listed in Supplementary Table 3 .
Construction of gBΔ71. The crystallization construct gBΔ 71 encodes residues 72-904 of FL-gB, an N-terminal honeybee melittin signal sequence, and a C-terminal His 6 tag in a pFastBac1 vector (pRC4). This construct lacks the signal peptide, residues 1-29, which is cleaved during protein maturation and is absent from the mature gB, and the proteolytically sensitive N terminus, residues 30-71, that causes heterogeneity in gB samples. To make pRC4, the sequence encoding the gB CTD with a C-terminal His 6 tag was excised from pKH11 using NheI and MfeI and subcloned into the sequence for full-length, untagged gB (pEV34), generating FL-gB (pRC2). Next, SOE PCR using flanking primers 5′ -CGCGGAATTCAAAGGCCTAC-3′ and 5′ -CTCGAC GATGCAGTTTACCG-3′ along with mutagenesis primers 5′ -ATCTATGCGA ACAAAAAACCGAAAAACCCAACG-3′ and 5′ -GGTTTTTTGTTCG CATAGATGTAAGAAATGTACAC-3′ was used to remove codons 30-71.
Expression and purification of gBΔ71. Recombinant baculovirus encoding C-terminally His 6 -tagged HSV-1 gBΔ 71 was generated using Bac-to-Bac technology (Thermo Fisher). Spodoptera frugiperda (Sf9) cells (Thermo Fisher) were grown in Sf900-SFM medium (Thermo Fisher) to a density of 2 × 10 6 cells/ ml and infected with recombinant baculovirus by adding 14 ml of the viral stock from the third passage (P3) to 1.4 liters of cells. Sixty to 72 h after infection, cells were harvested by centrifugation at 4,000 g and resuspended in 50 mM Tris pH 8.0, 150 mM NaCl, and 10% glycerol (solubilization buffer, SB) plus 0.1 mM PMSF. After an additional centrifugation, cell pellets were frozen at -80 °C. Prior to purification, cell pellets were defrosted at 4 °C and resuspended in SB with 1 mM PMSF and 1 × Roche protease inhibitor cocktail. The suspension was lysed by passing it three times through an M-110S microfluidizer, according to the manufacturer's instructions, and clarified by centrifugation at 4,000 g for 25 min. Crude membrane fraction was isolated from the clarified lysate by ultracentrifugation at 150,000 g for 90 min and resuspended in 50 ml of SB plus 0.1 mM PMSF using a dounce homogenizer. Membrane proteins were extracted by adding 1. Crystallization and structure determination. Initially, gBΔ 71 crystallized in several maltosides, yet the MPR-TMD-CTD portion was largely unresolved in these crystals. To stabilize the membrane regions, we obtained crystals in the presence of amphipols. Protein in GF buffer was concentrated to 3.6 mg/ml using an Ultra-4 (molecular weight cutoff of 100 kDa) concentrator (Millipore EMD) and passed through a 0.1-μ m Ultrafree centrifugal filter (Millipore EMD). The protein was supplemented with A8-35 (Anatrace), mixed gently, and incubated at room temperature for 30 min. Crystals were grown by vapor diffusion in hanging drops containing 1 μ l of protein and 1 μ l of reservoir solution. Crystals appeared after 3-4 weeks and grew for an additional week. Higher PEG-3350 concentrations (16-18%) favored the formation of crystals in the P321 space group, whereas 12-14% PEG-3350 yielded crystals in the H32 space group. Some drops in the middle of this range contained H32 crystals at their periphery and P321 crystals in their center, potentially owing to uneven distribution of precipitant, detergent, and/or amphipol. While we hypothesize that association with A8-35 is necessary to stabilize the TMD and enable P321 packing of gB, this highly anionic amphipol is thought to hinder crystallization, thereby requiring increased precipitant 60 . The P321 crystal was grown using gBΔ 71 in 0.05% DDM and 0.01% A8-35 and reservoir solution containing 16% PEG-3350, 0.1 M HEPES pH 7.2, and 0.15 M sodium formate. The H32 crystal was grown using gBΔ 71 in 0.075% UM and 0.0075% A8-35 and reservoir solution containing 11% PEG-4000, 0.1 M Tris-HCl pH 7.5, and 0.1 M NaCl. Cryoprotectant solution containing 20% glycerol was prepared by mixing two parts 50% glycerol with three parts reservoir solution. Crystals were cryoprotected by brief incubation in cryoprotectant followed by plunging into liquid nitrogen. X-ray data were collected at 100 K on beamlines 24ID-E and 24ID-C at the Advanced Photon Source at the Argonne National Laboratories. Both the P321 and H32 datasets were processed using XDS 61 as implemented in the Northeastern Collaborative Access Team (NE-CAT) software pipeline RAPD (https://rapd.nec.aps.anl.gov).
A 3.6-Å-resolution P321 dataset was used to determine the structure by molecular replacement in Phaser 62 using the HSV-1 gB ectodomain (PDB 2GUM) 9 as a search model. There is a single gB polypeptide in the asymmetric unit, and a gB trimer is generated by a threefold crystallographic symmetry operation. The initial electron density revealed the locations of the MPR, TMD, and CTD, in addition to the ectodomain. The ectodomain adopted the postfusion conformation, presumably during membrane disruption caused by detergent extraction. The overall fold of the ectodomain within the gBΔ 71 structure is very similar to that of isolated gB ectodomain 9 , with r.m.s. deviation of 1.00 over 576 residues. An initial MPR-TMD-CTD model was built manually into the experimental density using Coot 63 and refined against data truncated to 3.6-Å resolution. Prior to refinement, 8% of reflections were set aside for cross-validation. Model refinement included gradient minimization refinement of xyz coordinates and individual thermal parameters with optimization of X-ray/stereochemistry and X-ray/ADP weights, as implemented in phenix.refine 64 . Secondary structure restraints were used throughout refinement. Rotamer restraints were imposed until the last stage of refinement. Iterative rounds of model rebuilding were carried out in Coot. The final model encompassed residues 104-865 (unresolved 71-103, 477-491, 726-752, 771-775, 818-829, 866-904, and the C-terminal His 6 tag) and four N-acetylglucosamine moieties at residues N141, N398, and N674. Sequence 754-770 was assigned to a helical density within the MPR region in the vicinity of the TMD, but, owing to poor side chain density, its precise register is unclear. The unresolved loop following residue 817 was also paired with the nearest residue, 830, rather than this position in more distant symmetry mates. This path is suggested by the weak electron density, and of the three possible pairings, it is the only one that does not require the polypeptide chain to make a long detour. According to MolProbity as implemented in phenix.refine 64 , 95.7% of residues lie in the most favored regions of the Ramachandran plot and 4.3% lie in the additionally allowed regions. Relevant crystallographic statistics are listed in Table 1 .
A 4.0-Å-resolution H32 dataset was used to determine the structure by molecular replacement in Phaser 62 using the HSV-1 gB ectodomain structure (PDB 2GUM) 9 as a search model. As in P321 crystals, there is a single gB polypeptide in the asymmetric unit and a gB trimer is generated by a threefold crystallographic symmetry operation. While the MPR and most of the TMD were visible in the initial electron density, in addition to the ectodomain, the CTD was unresolved. The model of MPR-TMD was built manually into the experimental density using Coot and refined against 4.1-Å-resolution data. Prior to refinement, 10% of reflections were set aside for cross-validation. Model refinement included gradient minimization refinement of xyz coordinates and individual thermal parameters, all as implemented in phenix.refine. Secondary structure restraints were used throughout refinement. Rotamer restraints were imposed until the last stage of refinement. Iterative rounds of model rebuilding were carried out in Coot. The final model encompassed residues 103-794 (unresolved 71-101, 483-489, 731-752, 796-904, and the C-terminal His 6 tag) and seven N-acetylglucosamine moieties at residues N141, N398, N430, and N674. As in the P321 structure, the precise location of residues 753-770 cannot be ascertained. But, residues 726-730 and the hinge between the MPR and TMD, residues 771-774, were resolved in the H32 structure, in contrast to the P321 structure. According to MolProbity, 92.56% of residues lie in the most favored regions and 7.13% lie in the additionally allowed regions of the Ramachandran plot. Two residues, P130 and P774, are Ramachandran outliers. Relevant crystallographic statistics are listed in Table 1 CTD expression and purification. Soluble CTD proteins were expressed in E. coli Rosetta pLysS cells (Novagen). Freshly transformed Rosetta cells were grown at 37 °C in LB medium supplemented with 50 μ g/ml kanamycin Spin label mobility was estimated using the inverse width (1/Δ H) of the central line of the nitroxide CW-ESR spectrum 27 . The Φ and 1/Δ H data for residues in h3 were fitted to the periodic function
where y is either Φ or 1/Δ H, n is residue number, N is the periodicity, b is offset, and a is a constant. The obtained N values for Φ and 1/Δ H were 3.65 and 3.75, respectively. All fittings of CW-ESR power saturation data and spin-label mobility were performed in OriginLab software (OriginLab Corporation). The measurements were performed twice on most of the singly labeled residues in h3 and the 5PC-labeled sample. 
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